Rodney Hicks
罗德尼·希克斯
MD, FRACP
Professor and Director, Theranostics and Nuclear Medicine治疗诊断学与核医学主任兼教授
👥Biography 个人简介
Prof. Rodney Hicks is a world leader in theranostics and PRRT at Peter MacCallum Cancer Centre. He pioneered clinical PRRT programs in Australia and has conducted landmark research defining patient selection, dosimetry, and outcomes for Lu-177 DOTATATE in advanced NETs.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
PRRT Clinical Development
Established one of the first comprehensive PRRT programs in the Asia-Pacific region, defining dosimetry protocols and patient selection criteria now used internationally for Lu-177 DOTATATE therapy.
Theranostics Framework
Articulated the theranostics paradigm—matching SSTR imaging for patient selection with targeted radionuclide therapy—transforming how nuclear medicine is integrated into NET oncology.
Representative Works 代表性著作
PRRT of neuroendocrine tumours with Lu-177: clinical outcomes and toxicity
Journal of Nuclear Medicine (2005)
Early systematic analysis of Lu-177 PRRT outcomes and safety, providing pivotal data that underpinned subsequent regulatory approval trials.
Theranostics: a new paradigm for cancer treatment
Cancer Imaging (2014)
Influential paper codifying the theranostics concept, integrating molecular imaging diagnostics with targeted radionuclide therapy for personalized cancer treatment.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
James Yao
MD Anderson Cancer Center
Matthew Kulke
Boston Medical Center / Boston University
Emily Bergsland
University of California, San Francisco (UCSF)
Eric Liu
Rocky Mountain Cancer Centers
关注 罗德尼·希克斯 的研究动态
Follow Rodney Hicks's research updates
留下邮箱，当我们发布与 Rodney Hicks（Peter MacCallum Cancer Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment